The HEV IgM GENLISA ELISA is intended for the qualitative determination of Hepatitis E Virus IgM in human serum and plasma.
Gut health is very important in order to maintain healthy life. The gut microbiome test which can be taken in the comfort of your home can reveal any imbalance in your gut flora. You can take corrective action to reduce your risk of diseases like Irritable Bowel Syndrome, diabetes, obesity, depression and hypertension caused by an unhealthy gut.
Hindustan Wellness - The India's largest Diagnostic centre and Pathology lab in Delhi & NCR with a focus on providing quality Preventive Health Care Lab services at affordable costs. For more please call us 9810981083.
Abdominal Drainage Kit -Soft abdominal drainage catheter with atraumatic rounded open distal end. -Radio opaque line on catheter. -Collection bag ( 2000 ml). -E.T.O. Sterile & Pyrogen Free. General Surgery -Size : 16,20,24,28,32,36 FG
Price - Rs. 1,350.00 These GDH-FAD Blood Glucose Monitoring Testing Strips have bi-directional blood sucking technology. Special electrode pins design helps in getting stable test results Features - Test method GDH-FAD Bi-directional blood sucking Easy to use Auto Coding Care - Handle with care Keep away from children Dispose off the testing strips properly Classified memory before and after meals
Price - Rs. 1,150.00 These GOD Blood Glucose Monitoring Testing Strips have bi-directional blood sucking technology. Special electrode pins design helps in getting stable test results Features - Test method GOD Bi-directional blood sucking Easy to use Auto Coding Care - Handle with care Keep away from children Dispose off the testing strips properly Classified memory before and after meals
Price - Rs. 1,100.00 Dr. Odin Accugence Blood Glucose Test Strips (GOD) are thin strips with a chemical reagent system that works with the Dr. Odin Accugence multi-monitoring meter to measure the glucose concentration in whole blood. Blood is applied to the end tip of the test strip. Features - Test method GOD Accurate test result Contains a total of 50 testing strips To be used with Dr. Odin Accugence Lowest sample volume Automatic applying blood sample
Dr. Odin Accugence is a multi-monitoring system for 4 in 1 testing. This product offers a simple and effective solution for your demand of testing with clinically proven accuracy, fast test time, and tiny sample volume in one system. It can test Blood Glucose Level (GOD/FAD-GDH), Uric Acid Testing and Blood Ketone Testing. Features: 4 in 1 testing 5 range indicators Easy strip ejection Auto strip recognition Care: To use twist-off the protective cap Smooth, polished surface for reduced friction during penetration Guaranteed sterility to fulfill hygienic requirements Read the manual carefully before use Use under medical supervision Keep out of the reach of children Additional Info: Model number: NA Warranty: Lifetime Easy to use Our lancets have an advanced glide control system for convenient use Made from natural & super-fine round points to ensure a less painful prick
Dr. Odin Accugence is a multi-monitoring system for 4 in 1 testing. This product offers a simple and effective solution for your demand of testing with clinically proven accuracy, fast test time, and tiny sample volume in one system. It can test Blood Glucose Level (GOD/FAD-GDH), Uric Acid Testing and Blood Ketone Testing. Features: 4 in 1 testing 5 range indicators Easy strip ejection Auto strip recognition Care: To use twist-off the protective cap Smooth, polished surface for reduced friction during penetration Guaranteed sterility to fulfill hygienic requirements Read the manual carefully before use Use under medical supervision Keep out of the reach of children Lancet is for single use only Additional Info: Model number: NA Warranty: lifetime Easy to use Our Lancets have an advanced glide control system for convenient use Made from natural & super-fine round points to ensure a less painful prick
COVID 19 Antibody Test Kits COVID 19 NIV Test Kits
One step, rapid immunochromatographic assay for detectionof NS1Ag of all serotypes of Dengue virus in human serum orplasmaDetection of infection prior to sero - conversionDetects all serotypes (DEN-1,DEN-2,DEN-3, DEN-4)Specimen volume : 90 - 100 ul of Serum/PlasmaNo sample preparation requiredResult interpretation time: 20 minsSensitivity :> 95%. Specificity : =95%
Testing 1
Test Test Test Test Test Test
test test test test test test test test test test test test test test test test test test test test test test test test test test test
Anti-SARS-CoV-2 Rapid Test, COVID-19 1. Easier: No special equipment needed, Intuitive visual interpretation. 2. Rapid: Quick sampling by fingertip blood, Results in 10-15min. 3. Accurate: Results with IgG and IgM respectively. 4. Application: as screening tool for potential suspect patients in large numbers. Testing kit is FDA Emergency Use Authorization (EUA) Approved Testing kit is CE MARKED-IVD * Instruction for Use * Interpretation Guide * SARS-CoV-2 immunoassays * Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit * Anti-SARS Rapid Test Brochure * COVID-19 Catalog * EUA Approval Letter * Fact Sheet for Healthcare Providers * FDA Letter * Fact Sheet for Recipients * FAQ * CE IVD Notification Certificate Antibody Performance Measure Estimate of Performance 95% Confidence Interval IgM Sensitivity (PPA) 95.7% (289/302) (92.8%; 97.5%) IgM Specificity (NPA) 99.7% (311/312) (98.2%; 99.9%) IgG Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%) IgG Specificity (NPA) 99.4% (310/312) (97.7%; 99.8%) Combined Sensitivity (PPA) 99.0% (299/302) (97.1%; 99.7%) Combined Specificity (NPA) 99% (309/312) (97.2%; 99.7%) Combined PPV at prevalence = 5% 84.4% (64.6%; 94.6%) Combined NPV at prevalence = 5% 99.9% (99.8%; 100%) Testing kit is FDA Emergency Use Authorization (EUA) Approved Testing kit is CE MARKED-IVD * Instruction for Use * Interpretation Guide * SARS-CoV-2 immunoassays * Accuracy of the Anti-SARS-CoV-2 Rapid Test Kit * Anti-SARS Rapid Test Brochure * COVID-19 Catalog * EUA Approval Letter * Fact Sheet for Healthcare Providers * FDA Letter * Fact Sheet for Recipients * FAQ * CE IVD Notification Certificate
Product Details: Number of Reactions(Preps)/Kit :30T Brand : SD Biosensor ICMR Approved : Yes Result Time (Rapid Kits) : 10 min CAT No : RK019-30 STANDARD Q HIV 1/2 Ab 3-Line performs qualitative analysis by detecting antibodies specific to HIV-1 (including Group O) and HIV-2 in serum, plasma and whole blood using immunochromatography. With a simple test method, HIV infection status can be discriminated, and with its high sensitivity and specificity, the screening test result can be obtained within 10 minutes. Easy to use, Easy to read and interpret Discrimination between HIV-1 and HIV-2 antibodies Room temperature storage Performance Sensitivity : 100% (74/74)/ Specificity : 100% (232/232)
A rapid in vitro qualitative immunoassay for detection of antibodies to the Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) Clear, dependable results in 15 minutes Requires minimal training and no equipment So easy it can be used at the lowest levels of health care service Can use whole blood or serum/plasma Collection can be by fingerstick or venipuncture No refrigeration required Storage conditions 2-30�°C
COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of
COVID-19 serology test.Cellex qSARS-CoV-2 IgG/IgM Rapid Test.qSARS-CoV-2 IgG/IgM Rapid Test Cassette.FDA Grants Emergency Authorization for First Rapid Antibody Test for COVID-19
CAT No : RCHM-02071. The CareStar COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
